RVPH - Nilai pasar Reviva Pharmaceuticals Holdings Inc.

Logo perusahaan publik Reviva Pharmaceuticals Holdings, Inc. (RVPH)

This price chart for Reviva Pharmaceuticals (RVPH) illustrates the price action of an asset with a market capitalization of 0.00. Reviva Pharmaceuticals (RVPH) faces a capital shortage and a lack of profitability while awaiting the results of key tests for its schizophrenia drug. The business focuses on developing safe treatments for CNS disorders and psoriasis, while adhering to strict laboratory waste disposal regulations.

Reviva Pharmaceuticals Holdings, Inc. - Nilai pasar RVPH (periode 04.07.2022 - 16.05.2026)

RVPH (Reviva Pharmaceuticals, Inc.): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Reviva Pharmaceuticals (RVPH):
Kutipan saham Reviva Pharmaceuticals Holdings, Inc.|RVPH - Bagan rega target|Nilai pasar Reviva Pharmaceuticals, Inc.
Analisis fundamental perusahaan:RVPH (Reviva Pharmaceuticals Holdings, Inc.)
Sampel barang revivapharma.com

Reviva Pharmaceuticals focuses on neurology, outsourcing its production and trials to third-party contractors. The company's current market capitalization reflects the market value of all the issuer's shares. This calculated metric allows for the exclusion of speculative expectations to assess the business's actual margin of safety. The trend of this indicator is critical for monitoring delisting risks under negative scenarios. The final value determines the company's fundamental stability in the face of systemic degradation.

Pesaing wigati

Biogen - Biji pasar|Neurocrine - Nilai pasar|RGC - Nilai pasar|Biji pasar AXSM|ACAD: Kapitalisasi pasar|xenon-pharma.com - Nilai pasar|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|Nilai pasar CeriBell, Inc.|PRTA: Nilai pasar|Kapitalisasi pasar ALEC|ANNX - Nilai pasar|Omeros - Biji pasar|Neurogene Therapeutics - Nilai pasar|AC Immune - Kapitalisasi pasar|Kapitalisasi pasar voyagertherapeutics.com VYGR|NMRA (Neumora Therapeutics, Inc.) - Biji pasar|SCLX (Scilex Holding) - Nilai pasar|TVGN (Tevogen Bio Holdings, Inc.) - Kapitalisasi pasar|Kapitalisasi pasar Alpha Cognition Corp|Biji pasar CGTX (Cognition Therapeutics, Inc.)|IKT (inhibikase.com) - Nilai pasar|Nilai pasar Cassava Sciences SAVA|ASRT (Assertio Holdings) - Biji pasar|Coya - Kapitalisasi pasar|Nilai pasar VTGN (Vistagen Therapeutics)|OVID: Kapitalisasi pasar|acumenpharm.com (ABOS) - Kapitalisasi pasar|Nilai pasar CervoMed|ATHE: Nilai pasar|Nilai pasar Clene Inc. (CLNN)|Biji pasar pepgen.com PEPG|Kapitalisasi pasar JUNS (Jupiter Neurosciences)|Kapitalisasi pasar relmada.com RLMD|Annovis Bio - Kapitalisasi pasar|Grace Therapeutics, Inc. (GRCE) - Biji pasar|AIFF: Kapitalisasi pasar|Nilai pasar Klotho Neurosciences (KLTO)|Biji pasar NRSN|Kapitalisasi pasar MetaVia, Inc.|Biji pasar NRXS (NeurAxis)|Nilai pasar HSDT|Kapitalisasi pasar PASG (Passage Bio)|Kapitalisasi pasar Neuphoria Therapeutics, Inc. (NEUP)|Minerva Neurosciences - Kapitalisasi pasar|athira.com (ATHA) - Biji pasar|ADXN: Kapitalisasi pasar|Alzamend Neuro (ALZN) - Kapitalisasi pasar|Nilai pasar Cyclerion Therapeutics Inc.|Nilai pasar PTIX|Nilai pasar Pasithea Therapeutics (KTTA)|Kapitalisasi pasar cortigent.com|Nilai pasar Avenue Therapeutics, Inc. ATXI|Nilai pasar BCLI|CARA: Biji pasar|CHRO: Nilai pasar|eliemtx.com (ELYM) - Nilai pasar|Biji pasar ITCI (Intra-Cellular Therapies, Inc.)|LBPH (Longboard Pharmaceuticals, Inc.) - Kapitalisasi pasar|MRNS: Nilai pasar|Nilai pasar NKGen (NKGN)|NeuroBo Pharma - Kapitalisasi pasar|Kapitalisasi pasar SAGE (Sage Therapeutics, Inc.)|synaptogen.com (SNPX) - Nilai pasar|TRVN: Biji pasar|VIGL - Kapitalisasi pasar|Anew Medical, Inc. (WENA) - Nilai pasar|Cerevel Corp - Nilai pasar